BETA-CAROTENE SUPPLEMENTATION RESULTS IN AN INCREASED SERUM AND COLONIC MUCOSAL CONCENTRATION OF BETA-CAROTENE AND A DECREASE IN ALPHA-TOCOPHEROL CONCENTRATION IN PATIENTS WITH COLONIC NEOPLASIA
S. Mobarhan et al., BETA-CAROTENE SUPPLEMENTATION RESULTS IN AN INCREASED SERUM AND COLONIC MUCOSAL CONCENTRATION OF BETA-CAROTENE AND A DECREASE IN ALPHA-TOCOPHEROL CONCENTRATION IN PATIENTS WITH COLONIC NEOPLASIA, Cancer epidemiology, biomarkers & prevention, 3(6), 1994, pp. 501-505
The aim of this study was to evaluate the colonic mucosal beta-caroten
e (BC) concentration following supplementation with BC and to determin
e if an increase in BC concentration influences vitamin E (alpha-tocop
herol) status. The concentration of BC and alpha-tocopherol was assess
ed in serum and colonic tissue obtained from subjects with a history o
f colonic polyps or resected cancer (Dukes A, B1, or B2). Serum and mu
cosal biopsy samples were obtained prior to and following 3 months dai
ly p.o. supplementation with 30 mg of BC or placebo. The concentration
of BC was significantly increased in serum and colonic mucosa from bo
th polyp and cancer subjects following supplementation as compared to
presupplementation values and values from subjects receiving a placebo
. The concentration of alpha-tocopherol in serum from cancer subjects
was significantly decreased in samples obtained at the end of 3 months
of BC supplementation as compared to placebo-matched controls. In BC-
supplemented polyp subjects the tissue concentration of alpha-tocopher
ol was also significantly decreased relative to presupplementation val
ues. The results indicate that BC supplementation does result in a sig
nificant accumulation of BC in the colonic mucosa but that the alpha-t
ocopherol concentration in both serum and colonic tissue may be compro
mised by an increased intake of BC. The mechanism for the decrease in
alpha-tocopherol in conjunction with the increase in BC will require f
urther study in order to develop strategies which will prevent vitamin
E deficiency in BC-supplemented individuals.